MSN Laboratories Private Limited Moxifloxacin Export Data — India (DGFT 2022–2026)

Name: MSN Laboratories Private Limited Moxifloxacin Export Records India — #2 Exporter, 89 Shipments, $2.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Moxifloxacin

India Pharmaceutical Trade Intelligence

$32.8M336 Suppliers137 CountriesHS 30049099

ExportsIndia → NIGERIA44.8%India → UNITED STATES17.5%

ImportsUNITED STATES → India$160.3B BRAZIL → India$30.7B

#1 Buyer: NATIONAL TUBERCULOSIS

MSN Laboratories Private Limited — Moxifloxacin Exporter #2 | $2.3M Trade Value | TransData Nexus | TransData Nexus

MSN Laboratories Private Limited — Moxifloxacin Exporter Profile

Indian Pharmaceutical Exporter · #2 for Moxifloxacin · $2.3M export value · DGFT Verified

MSN Laboratories Private Limited is the #2 Indian exporter of Moxifloxacin with $2.3M in export value and 89 verified shipments. MSN Laboratories Private Limited holds a 7.0% market share in Moxifloxacin exports across 13 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.

MSN Laboratories Private Limited — Moxifloxacin Export Profile: Buyers & Destinations

MSN Laboratories Private Limited Moxifloxacin export treemap — buyers and destination countries | TransData Nexus

Where Does MSN Laboratories Private Limited Export Moxifloxacin?

Country	Value	Shipments	Share
NETHERLANDS	$1.0M	30	52.4%
UNITED STATES	$291.7K	10	15.0%
AUSTRALIA	$222.2K	12	11.5%
UNITED KINGDOM	$179.3K	6	9.2%

Who Are the Top Buyers of Moxifloxacin from MSN Laboratories Private Limited?

Buyer	Country	Value	Orders
TO THE ORDER OF	AUSTRALIA	$505.7K	22
I+SOLUTIONS	NETHERLANDS	$302.8K	9
I+ SOLUTIONS,	NETHERLANDS	$290.3K	7
NOVADOZ PHARMACEUTICALS LLC	UNITED STATES	$249.6K	8
APOTEX PTY LTD	AUSTRALIA	$121.1K	8
TILLOMED LABORATORIES LIMITED	UNITED KINGDOM	$112.1K	4
GDF TILBURG SRS D102TC	NETHERLANDS	$76.2K	5
I SOLUTIONS POLARNERBAAN	NETHERLANDS	$50.0K	1
MSN LABS PERU SAC	PERU	$45.4K	5
APORTEX PTY LTD	AUSTRALIA	$40.4K	2

MSN Laboratories Private Limited supplies Moxifloxacin to 20 buyers globally. The largest buyer is TO THE ORDER OF (AUSTRALIA), followed by I+SOLUTIONS (NETHERLANDS) and I+ SOLUTIONS, (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Moxifloxacin Formulations Does MSN Laboratories Private Limited Export?

Product Description / Formulation	Value	Shipments
FLOXSAFE 400MG(MOXIFLOXACIN 400MG)FCA +PFRC 10X10S	$240.3K	6
MSN PHARMACEUTICALS PRODUCT NAME FLOXSAFE 400MG MOXIFLOXACIN 400MG FCA PFRC10x10s	$132.9K	4
Moxifloxacin Tablets 400mg, 30s NDC: 72205-001-30	$108.3K	3
MOXIFLOXACIN-APO TABLETS	$101.2K	4
FLOXSAFE 400MGMOXIFLOXACIN 400MGFCA +PFRC 10X10S	$82.9K	2
MOXIFLOXACIN FC TABS 400MG X 5 TILLOMED	$81.1K	3
MOXIFLOXACIN-APO TABLETS-MSN PHARMA	$60.3K	6
FLOXSAFE 400MG(MOXIFLOXACIN 400MG)FCA+PFRC 10 X 10S	$50.0K	1
FLOXSAFE 400MG(MOXIFLOXACIN 400MG)FCA +PFRC 10X10SNOS	$50.0K	1
FLOXSAFE 400MG(MOXIFLOXACIN 400MG)FCA +PFRC 10X10S BATCH NO- DRD11370A MFG DATE- NOV 2023 EXP DATE- OCT 2027NOS	$50.0K	1

MSN Laboratories Private Limited exports 58 distinct Moxifloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FLOXSAFE 400MG(MOXIFLOXACIN 400MG)FCA +PFRC 10X10S with 6 shipments worth $240.3K.

How Does MSN Laboratories Private Limited Compare to Nearest Moxifloxacin Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	MSN LABORATORIES PRIVATE LIMITED ★	$2.3M	89	13	$25.9K
4	MICRO LABS LIMITED	$2.3M	86	14	$26.5K
3	EUGIA PHARMA SPECIALITIES LIMITED	$1.9M	39	1	$50.0K

MSN Laboratories Private Limited ranks #2 among 336 Indian Moxifloxacin exporters. Average shipment value of $25.9K compared to the market average of $42.4K. The closest competitors by value are MICRO LABS LIMITED and EUGIA PHARMA SPECIALITIES LIMITED.

Which Indian Ports Ship Moxifloxacin Exports?

Port	Shipments	% Share
SAHAR AIR	311	12.9%
SAHAR AIR CARGO ACC (INBOM4)	263	10.9%
DELHI AIR CARGO ACC (INDEL4)	152	6.3%
DELHI AIR	132	5.5%
NHAVA SHEVA SEA (INNSA1)	126	5.2%
Bombay Air	119	4.9%
CHENNAI AIR	111	4.6%
CHENNAI AIR CARGO ACC (INMAA4)	93	3.9%

Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Moxifloxacin Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)

Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)

In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.

MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.

MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Moxifloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: MSN Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 89 individual customs records matching MSN Laboratories Private Limited exporting Moxifloxacin, covering 58 formulations to 13 countries via 20 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 137+ countries, 731+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Moxifloxacin

Moxifloxacin

MSN Laboratories Private Limited — Moxifloxacin Exporter Profile

MSN Laboratories Private Limited — Moxifloxacin Export Profile: Buyers & Destinations

Where Does MSN Laboratories Private Limited Export Moxifloxacin?

Who Are the Top Buyers of Moxifloxacin from MSN Laboratories Private Limited?

What Is India's Total Moxifloxacin Export Value and How Much Does MSN Laboratories Private Limited Contribute?

What Is the Average Shipment Value for MSN Laboratories Private Limited's Moxifloxacin Exports?

How Does MSN Laboratories Private Limited Compare to Other Indian Moxifloxacin Exporters?

What Moxifloxacin Formulations Does MSN Laboratories Private Limited Export?

Regulatory Requirements: Exporting Moxifloxacin to Key Markets

United States — FDA

Australia — TGA

How Does MSN Laboratories Private Limited Compare to Nearest Moxifloxacin Exporters?

Which Indian Ports Ship Moxifloxacin Exports?

Moxifloxacin — Export Intelligence Video

Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Moxifloxacin Exports

MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards

About MSN Laboratories Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Moxifloxacin Export Data from MSN Laboratories Private Limited

Moxifloxacin Stats

Company Overview

Top Products by MSN Laboratories Private Limited

Related Analysis

Need Detailed Export Data?

Data Source